$SLQT

Berman Tabacco Announce s Investigation of SelectQuote, Inc. (NYSE:SLQT) - SelectQuote (NYSE:SLQT)

BOSTON, Nov. 24, 2025 ( GLOBE NEWSWIRE ) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. ( "SelectQuote" ) ( NYSE:SLQT ) allegedly receiving illegal payments from health insurance providers.

Original reporting
Benzinga · Globe Newswire
Published Nov 24, 2025, 9:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 24, 2025, 10:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Berman Tabacco Announce s Investigation of SelectQuote, Inc. (NYSE:SLQT) - SelectQuote (NYSE:SLQT) — source image
Decision brief

The 30-second read

$SLQTBearishMed
01

Why it matters

Legal investigations often lead to short-term declines; however, the long-term impact depends on investigation outcomes.

02

Market read

The news is highly relevant for SLQT and potentially impactful for the insurance and financial sectors.

03

What to watch

Potential for legal resolution or settlement that might mitigate negative impact; broader market conditions could overshadow company-specific news.

Timing: Immediate, as news is recent and ongoing investigation.

Background

Berman Tabacco, a law firm, is investigating potential illegal payments involving SLQT, indicating possible legal or regulatory issues.

Company-level read

Ticker impact

$SLQTBearishHigh confidence
Context

High relevance due to a strong negative sentiment (-0.303717).

Expected impact

Possible decline of 5-10% in the near term, depending on investigation developments.

Evidence & confidence

SLQT has a high relevance score (0.767534), and the news directly pertains to the company, increasing the likelihood of a significant short-term decline.

Market effects

Potential negative sentiment in the insurance and financial sectors due to legal investigations.

Limited regional impact, primarily affecting US-based insurance and financial companies.

Minimal, as the news pertains to a US-listed company and sector.

Counterpoint

The investigation may be a temporary setback; if no substantive charges are found, the stock could recover and rebound.

Key entities

  • Berman Tabacco

    Law firm conducting the investigation.

  • SelectQuote, Inc.

    The subject of the investigation, listed on NYSE as SLQT.

Related articles

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$RBAHigh

Why This U.S. Auto Retail Stock is Barclays’ Top Pick Right Now

Barclays named RB Global Inc (RBA) its top U.S. auto retail pick, citing an attractive valuation at 12.7x EV/EBITDA, market share gains, and cyclical improvements in its Heavy Equipment & Transportation segment. RBA reported Q2 2026 revenue of $1.32B, beating estimates, with 11% gross transaction value growth. Barclays expects RBA to gain market share from Copart Inc (CPRT) in the salvage vehicle auction market.

$GHHighAI 8/10

Guardant ordered to pay $245m in DNA sequencing patent dispute

Guardant Health was ordered to pay $245.2m to TwinStrand Biosciences and the University of Washington for patent infringement. The ruling covers 11 products, including Guardant360 CDx, and includes damages, royalties, and interest. Guardant plans to appeal, while TwinStrand affirms its commitment to its intellectual property.

$KURAMed

Why is Kura Oncology stock surging today?

Kura Oncology's stock rose 11.6% in pre-market trading after CEO Troy Wilson bought 100,000 shares for $1.24 million, his second large purchase in a week. Analysts Citigroup and Jefferies reaffirmed positive ratings, citing strong commercial momentum for KOMZIFTI and Q2 earnings beat. The stock surpassed its 52-week high of $12.90.

$BEMed

Nancy Pelosi Made Millions On Nvidia Options. Now She’s Betting $3 Million On 1 AI Energy Stock

Paul Pelosi, spouse of House Speaker Nancy Pelosi, acquired 15,000 shares and 200 call options of Bloom Energy (BE) in July 2026, with a potential investment ranging from $3 million to $12 million. Bloom Energy reported Q2 2026 revenue of $1.065 billion, up 165.5% year-over-year, and raised full-year guidance to $3.9 billion to $4.2 billion. The stock closed at $204.02 on August 24, 2026, up 134.8% year-to-date. The Pelosi household also added to an existing Intel (INTC) position.